Stocks
Ionis Pharmaceuticals, Inc.IONS
NASDAQHealthcareBiotechnology$54.21-1.59%
Price as of · delayed, not real-time
A biotech firm specializing in RNA-targeted therapeutics, Ionis Pharmaceuticals develops treatments for rare and common diseases using antisense technology. The company has multiple FDA-approved drugs and a robust pipeline, making it a key player in genetic medicine. Investors monitor its clinical trial progress and partnerships with larger pharma companies.
Market Cap: $11.8B52W Range: $50.01-$86.74
Congressional Interest in Ionis Pharmaceuticals, Inc. (IONS)
6 members of Congress have disclosed 12 trades in Ionis Pharmaceuticals, Inc. (IONS), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
6
Buys
8
Sells
4
Who in Congress Is Trading IONS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-13 | Rohit Khanna | buy | $1K-$15K |
| 2023-03-06 | Daniel Goldman | sell | $1K-$15K |
| 2019-06-24 | Donna Shalala | sell | $1K-$15K |
| 2019-05-08 | Donna Shalala | buy | $1K-$15K |
| 2018-11-05 | JAMES B. RENACCI | buy | $1K-$15K |
| 2016-11-02 | Thomas MacArthur | buy | $1K-$15K |
| 2016-11-02 | Thomas MacArthur | buy | $15K-$50K |
| 2016-11-02 | Thomas MacArthur | buy | $1K-$15K |
| 2016-02-24 | Thomas MacArthur | buy | $1K-$15K |
| 2016-02-12 | Thomas MacArthur | buy | $1K-$15K |
| 2016-02-02 | Thomas MacArthur | sell | $15K-$50K |
| 2016-01-20 | Sheldon Whitehouse | sell | $1K-$15K |